Award Result:-(ICB/FW/EPSS6/MOH-GF-NFMIII/ARV/PH/20/23)
November 15, 2023
Tender Code: (ICB/FW/EPSS6/MOH-GF-NFMIII/ARV/PH/20/23
Award Status: Full Winners List
Award Date: 11/15/2023
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
|
Company Name: | ||||||||||||||||
| የኢትዮጵያ መድኃኒት አቅራቢ አገልግሎት | |||||||||||||||||
| Ethiopian Pharmaceuticals Supply Service | |||||||||||||||||
| Title: | Effective date : 21/01/2022 | ||||||||||||||||
| Official winner list | Rev. No.: 1 | ||||||||||||||||
| Official winner list of tender No : ICB/FW/EPSS6/MOH-GF-NFMIII/ARV/PH/20/23 | |||||||||||||||||
| Ser NO | Description | Unit | Quantity | No. of bidders to be awarded | Winner | Currency | Unit FOB price | allocated volume | Payment Term | port of shipment | Delivery Time | Remark | |||||
| Supplier | Country | ||||||||||||||||
| 1 | Atazanavir (ATV) + Ritonavir (RTV) – (300mg +100mg) – Tablet | 30 | 652,092 | 2 | Mylan Laboratories Limited | India | USD | 8.22 | 391,255 | Unconfirmed Irrevocable L/C | Mumbai | Within 60-90 days after L/C opening date | winner | ||||
| Emcure Pharmaceuticals Limited | India | USD | 8.70 | 260,837 | Unconfirmed Irrevocable L/C | Mumbai | Within 60-90 days after L/C opening date | 2nd least price | |||||||||
| 2 | Zidovudine – 10mg/ml – Oral Solution | 100 ml | 94,711 | 2 | Macleods Pharmaceuticals Limited | India | USD | 2.01 | 94,711 | Unconfirmed Irrevocable L/C | Delhi | Within 60-90 days after L/C opening date | winner | ||||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Proposed Winner list OF/TM/HO-14 1, 21/01/2022 | ||||||||||||||||
| Make sure that this is the correct issue before use | |||||||||||||||||
Reasons for Rejection
|
|
Company Name: | Document No: OF/TM/ HO-17 | ||||
| የኢትዮጵያ መድሃኒት አቅራቢ አገልግሎት | ||||||
| Ethiopian Pharmaceuticals Supply Services | ||||||
| Title: | Effective date : 21/01/2022 | |||||
| Reasons for Rejection | Rev. No.: 1 | Page 1 of 1 | ||||
| Tender no: ICB/FW/EPSS6/MOH-GF-NFMIII/ARV/PH/20/23 | ||||||
| Item No | Product Description | Name of competitor suppliers | Status | Reason of unsuccessfulness | Remark | |
| 1 | Atazanavir (ATV) + Ritonavir (RTV) – (300mg +100mg) – Tablet | Lupin Limited | Unsuccessful | Price incompetence | ||
| Pharmeda Healthcare Private Limited | Unsuccessful | Supplier/ Manufacturer was not listed on the latest GF prequalification list | ||||
| Shanghai Desano Bio-pharmaceutical Co.Ltd | Unsuccessful | Submitted bank guarantee issue date was after tender closing date | ||||
| 2 | Zidovudine – 10mg/ml – Oral Solution | Hetero Labs Limited | Unsuccessful | Offered unit didn’t comply with EPSS specification (Unit) | ||
| Pharmeda Healthcare Private Limited | Unsuccessful | Supplier/ Manufacturer was not listed on the latest GF prequalification list | ||||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reasons for Rejection OF/TM/HO-15, 0, 21/01/2022 | |||||
| Make sure that this is the correct issue before use | ||||||